Panel chair José Luis Molinuevo, MD, PhD, introduces a patient case study that follows the journey of a patient in the early stages of Alzheimer’s disease, throughout the symposium, from initial clinical presentation to receiving a diagnosis of MCI due to Alzheimer’s disease.
James Galvin, MD, describes the neurocognitive domains and use of informant measures and clinical assessments to detect early Alzheimer’s disease, discussing the advantages and disadvantages of each assessment. He then discusses the results of the neuropsychological assessment from the patient case and outlines the importance of assessing the appropriate cognitive domains during patient evaluation.
Disclosure: All panelists received honoraria from Biogen for participation in this symposium.
Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.